Achieve Life Sciences (ACHV) Interest & Investment Income (2010 - 2026)
Achieve Life Sciences (ACHV) posted Interest & Investment Income of $297000.0 for Q1 2026, down 30.44% on a QoQ basis from $427000.0 in Q4 2025, and down 7.76% year-over-year from $322000.0 in Q1 2025.
Achieve Life Sciences (ACHV) Interest & Investment Income (2010 - 2026) Analysis & Trends
Achieve Life Sciences' Interest & Investment Income history runs 17 years deep, the most recent figure standing at $297000.0 for Q1 2026.
- Quarterly Interest & Investment Income fell 7.76% year-over-year to $297000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 36.36% YoY) and the FY2025 annual result came in at $1.5 million, down 36.54% from the prior year.
- Interest & Investment Income was $297000.0 for Q1 2026 at Achieve Life Sciences, down from $427000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $833000.0 in Q2 2024 and bottomed at $4000.0 in Q1 2022.
- A 5-year average of $304235.3 and a median of $262000.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income soared 4725.0% — and 2025, when it tumbled 76.95%.
- Achieve Life Sciences' Interest & Investment Income stood at $118000.0 in 2022, then soared by 76.27% to $208000.0 in 2023, then soared by 131.73% to $482000.0 in 2024, then declined by 11.41% to $427000.0 in 2025, then slumped by 30.44% to $297000.0 in 2026.
- Business Quant data shows ACHV's Interest & Investment Income at $297000.0 in Q1 2026, $427000.0 in Q4 2025, and $554000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Achieve Life Sciences | 326.16 Mn | 326.16 Mn | - | 297,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 297,000.00 |
| Dec 31, 2025 | 427,000.00 |
| Sep 30, 2025 | 554,000.00 |
| Jun 30, 2025 | 192,000.00 |
| Mar 31, 2025 | 322,000.00 |
| Dec 31, 2024 | 482,000.00 |
| Sep 30, 2024 | 673,000.00 |
| Jun 30, 2024 | 833,000.00 |
| Mar 31, 2024 | 368,000.00 |
| Dec 31, 2023 | 208,000.00 |
| Sep 30, 2023 | 262,000.00 |
| Jun 30, 2023 | 193,000.00 |
| Mar 31, 2023 | 162,000.00 |
| Dec 31, 2022 | 118,000.00 |
| Sep 30, 2022 | 73,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 3,000.00 |